PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:06 AM ET

Sponsor Check › Person

MS
No photo found yet (own website and image search run after this page is viewed)

Mark Sieczkarek

Named as an officer, director or promoter on SEC Form D filings · CA · Jan 21, 2010 → Jan 18, 2022

4deals (issuers)
$160.1Mreported sold
202investors
14Form D filings
2010–2022years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Mark Sieczkarek is listed as an executive officer and director on 14 SEC Form D filings by 4 issuers between Jan 2010 and Jan 2022: NovaBay Pharmaceuticals, Inc. (Emeryville, CA — industry reported as "Other" — 2015–2019; $134M reported sold to 21 investors), SOLTA MEDICAL INC (Hayward, CA — other health care — 2010–2013; $25.5M reported sold to 173 investors), OT Global, LLC (El Segundo, CA — industry reported as "Other" — 2018–2022; $425K reported sold to 4 investors) and Orange Twist LLC (El Segundo, CA — other health care — 2020; $190K reported sold to 4 investors).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer and director, over about 12 years. Across those companies the filings report $160.1M sold in total.

Listed alongside Clint Carnell (7 shared filings), Gail Maderis (6 shared filings), PAUL FREIMAN (6 shared filings), Jared Smith (5 shared filings), JUSTIN HALL (4 shared filings) and 36 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.

3 of the issuers belong to the sponsor group Solta (3 issuers, $25.7M reported sold, 2010–2022).

What this means A sponsor group is one team that sets up a new company for each deal. Solta has 3 companies on file and $25.7M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 14 public filings for Mark Sieczkarek and found 14 differences, 4 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Mark Sieczkarek has not run yet — it is joining a line of 6,612 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Mark Sieczkarek..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

14 differences found between the filings for Mark Sieczkarek — 4 worth asking about (compared 14 filings on Oct 24, 2026)

Worth asking · Jan 21, 2010 – Mar 5, 2010

Amount sold went down between filings — SOLTA MEDICAL INC

The Jan 21, 2010 filing says $17,230,002 sold; the Mar 5, 2010 Form D says $4,750,000 sold — $12,480,002 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Sources
Worth asking · Jan 21, 2010 – Mar 5, 2010

Investor count went down between filings — SOLTA MEDICAL INC

The Jan 21, 2010 filing reports 9 investors; the Mar 5, 2010 Form D reports 4 investors.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Sources
Worth asking · Feb 26, 2016 – Jul 3, 2019

Paid seller listed without a CRD number: China Kington Asset Management Co. Ltd. — NovaBay Pharmaceuticals, Inc.

China Kington Asset Management Co. Ltd. is listed as receiving sales compensation on 4 filings (Feb 26, 2016 to Jul 3, 2019) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Sources
Worth asking · Mar 19, 2015 – Jun 4, 2015

Paid seller listed without a CRD number: Maxim Group LLC — NovaBay Pharmaceuticals, Inc.

Maxim Group LLC is listed as receiving sales compensation on 2 filings (Mar 19, 2015 to Jun 4, 2015) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Sources
Note · Feb 26, 2013 – Apr 9, 2013

Form D filed 42 days after the first sale — SOLTA MEDICAL INC

The filing says the first sale was Feb 26, 2013. The Form D was filed Apr 9, 2013 — 42 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 27 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Sources
Note · Feb 14, 2018 – Jul 3, 2019

Mark Sieczkarek's role changed at NovaBay Pharmaceuticals, Inc.: executive officer, director → director

The Feb 14, 2018 filing lists Mark Sieczkarek as executive officer, director; the Jul 3, 2019 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · Jun 4, 2015 – Feb 26, 2016

Mark Sieczkarek's role changed at NovaBay Pharmaceuticals, Inc.: director → executive officer, director

The Jun 4, 2015 filing lists Mark Sieczkarek as director; the Feb 26, 2016 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · Mar 19, 2015 – Jun 4, 2015

Offering amount changed between filings — NovaBay Pharmaceuticals, Inc.

The Mar 19, 2015 filing says $15,134,300 offered; the Jun 4, 2015 Form D/A says $26,582,871.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Jan 21, 2010 – Mar 5, 2010

Offering amount lowered between filings — SOLTA MEDICAL INC

The Jan 21, 2010 filing says $17,230,002 offered; the Mar 5, 2010 Form D says $15,500,000.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Sources
Note · Jan 8, 2010 – Dec 21, 2020

6 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Orange Twist LLC (latest filing Dec 21, 2020) · No amendment in the last 12 months on an offering that may still be open — OT Global, LLC (latest filing Dec 16, 2020) · No amendment in the last 12 months on an offering that may still be open — OT Global, LLC (latest filing Dec 27, 2019) · No amendment in the last 12 months on an offering that may still be open — OT Global, LLC (latest filing Dec 4, 2018) · No amendment in the last 12 months on an offering that may still be open — NovaBay Pharmaceuticals, Inc. (latest filing May 20, 2016) · and 1 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Sources
Note · Jan 21, 2010 – Feb 26, 2016

Mark Sieczkarek is written 2 different ways on the filings

listed as "Mark Sieczkarek" on 11 filings (from Jan 21, 2010), and "Mark M. Sieczkarek" on 3 filings (from Feb 26, 2016).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Sources
Note · Dec 4, 2018 – Jan 18, 2022

Industry group changed between filings — OT Global, LLC

"Other Health Care" (Dec 4, 2018 to Dec 16, 2020); then "Other" (Jan 18, 2022).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Sources
Note · Mar 4, 2020

Same name, different state: "Mark Sieczkarek" (L3) is a separate record

This page covers filings where the address state is CA. A separate record, "Mark Sieczkarek" with address state L3, is listed on 1 filing — most recently by Mawson Infrastructure Group Inc. (Mar 4, 2020). Both records have filings in the same period (Mar 4, 2020).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Dec 4, 2018 – Dec 27, 2019

Address moved from Costa Mesa, CA to El Segundo, CA — OT Global, LLC

The people listed on the Dec 4, 2018 filing give Costa Mesa, CA; on the Dec 27, 2019 filing they give El Segundo, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

4 of 12 offerings report sales commissions totalling $1,276,519; 1 reports finder's fees totalling $215,500; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Jan 18, 2022 D
OT Global, LLC
File 021-429770
$0$0$0None listed on this filingEDGAR ↗
Dec 21, 2020 D
Orange Twist LLC
File 021-383822
$0$0$0None listed on this filingEDGAR ↗
Dec 16, 2020 D
OT Global, LLC
File 021-383398
$0$0$0None listed on this filingEDGAR ↗
Dec 27, 2019 D
OT Global, LLC
File 021-356560
$0$0$0None listed on this filingEDGAR ↗
Jul 3, 2019 D
NovaBay Pharmaceuticals, Inc.
File 021-343482
$144,000$0$0CHINA KINGTON ASSET MANAGEMENT CO. LTD. no CRD number reported
via NONE
EDGAR ↗
Dec 4, 2018 D
OT Global, LLC
File 021-327150
$0$0$0None listed on this filingEDGAR ↗
Feb 14, 2018 D
NovaBay Pharmaceuticals, Inc.
File 021-305632
$359,040$0$0China Kington Asset Management Co. Ltd. no CRD number reportedEDGAR ↗
May 20, 2016 D
NovaBay Pharmaceuticals, Inc.
File 021-263628
$618,000 (est.)$0$0China Kington Asset Management Co. Ltd. no CRD number reportedEDGAR ↗
Feb 26, 2016 D
NovaBay Pharmaceuticals, Inc.
File 021-258212
$155,479$0$0China Kington Asset Management Co. Ltd. no CRD number reportedEDGAR ↗
Jun 4, 2015 D/A
NovaBay Pharmaceuticals, Inc.
File 021-236291
$0 (est.)$215,500 (est.)$0 (est.)Maxim Group LLC no CRD number reportedEDGAR ↗
Apr 9, 2013 D
SOLTA MEDICAL INC
File 021-194668
$0$0$0None listed on this filingEDGAR ↗
Mar 5, 2010 D
SOLTA MEDICAL INC
File 021-42048
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named Mark Sieczkarek on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Other · group: Solta

OT Global, LLC

El Segundo, CA · Dec 4, 2018 → Jan 18, 2022 · 4 filings
  • Jan 18, 2022 · D · $0 sold of $5,000,000 · 0 investors · min. $100,000 · role: Director (Manager) EDGAR ↗
  • Dec 16, 2020 · D · $189,873 sold of $1,250,000 · 4 investors · min. $2,500 · role: Director (Manager) EDGAR ↗
  • Dec 27, 2019 · D · $250,000 sold of $1,500,000 · 1 investors · min. $100,000 · role: Director (Manager) EDGAR ↗
  • Dec 4, 2018 · D · $250,000 sold of $2,000,000 · 1 investors · min. $100,000 · role: Director (Board of Managers) EDGAR ↗

Raised $425K from 4 investors (9% of the $5M target) as of the latest filing. Mark is listed as director on 4 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care · group: Solta

Orange Twist LLC

El Segundo, CA · Dec 21, 2020
  • Dec 21, 2020 · D · $189,873 sold of $1,250,000 · 4 investors · min. $2,500 · role: Director (Manager) EDGAR ↗

Raised $190K from 4 investors (15% of the $1.25M target) as of the latest filing. Mark is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pharmaceuticals

NovaBay Pharmaceuticals, Inc.

Emeryville, CA · Mar 19, 2015 → Jul 3, 2019 · 6 filings
  • Jul 3, 2019 · D · $2,400,000 sold of $2,400,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 14, 2018 · D · $5,984,000 sold of $5,984,000 · 1 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • May 20, 2016 · D · $7,791,000 sold of $11,791,000 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 26, 2016 · D · $2,830,804 sold of $2,830,804 · 3 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jun 4, 2015 · D/A · $26,582,871 sold of $26,582,871 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 19, 2015 · D · $15,134,300 sold of $15,134,300 · 14 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $134M from 21 investors (100% of the $2.4M target) as of the latest filing. Mark is listed as director, executive officer on 6 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other Health Care · group: Solta

SOLTA MEDICAL INC

Hayward, CA · Jan 21, 2010 → Apr 9, 2013 · 3 filings
  • Apr 9, 2013 · D · $25,499,999 sold of $25,499,999 · 173 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 5, 2010 · D · $4,750,000 sold of $15,500,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 21, 2010 · D · $17,230,002 sold of $17,230,002 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $25.5M from 173 investors (100% of the $25.5M target) as of the latest filing. Mark is listed as director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Mark Sieczkarek — Israel (as filed: L3), 1 issuer, Mar 4, 2020 → Mar 4, 2020 · no shared issuer

People around Mark 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Clint Carnell

Executive Officer, Director, Promoter · 7 shared filings (3 issuers) · also on 2 other issuers

Clint Carnell is on 5 issuers in total — a repeat sponsor. Their page lists every one.

GM
No photo found yet (own website and image search run after this page is viewed)
Person

Gail Maderis

Director · 6 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

PF
No photo found yet (own website and image search run after this page is viewed)
Person

PAUL FREIMAN

Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jared Smith

Director · 5 shared filings (2 issuers) · also on 5 other issuers

Jared Smith is on 7 issuers in total — a repeat sponsor. Their page lists every one.

TP
No photo found yet (own website and image search run after this page is viewed)
Person

THOMAS PAULSON

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

T. Alex McPherson

Director · 4 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

MW
No photo found yet (own website and image search run after this page is viewed)
Person

MIJIA (BOB) WU

Director · 4 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

JUSTIN HALL

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

XL
No photo found yet (own website and image search run after this page is viewed)
Person

XINZHOU (PAUL) LI

Director · 4 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

ES
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Stang

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

CM
No photo found yet (own website and image search run after this page is viewed)
Person

Cathy McCarthy

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

SF
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Fanning

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

John Glenn

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

Jeff Nardoci

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

HC
No photo found yet (own website and image search run after this page is viewed)
Person

Harold Covert

Director · 3 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

Doug Heigel

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

EK
No photo found yet (own website and image search run after this page is viewed)
Person

Edward Knowlton

Director · 3 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

HF
No photo found yet (own website and image search run after this page is viewed)
Person

H. Daniel Ferrari

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Massimo Radaelli

Director · 3 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

XL
No photo found yet (own website and image search run after this page is viewed)
Person

Xiaoyan (Henry) Liu

Director · 3 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

TZ
No photo found yet (own website and image search run after this page is viewed)
Person

TODD ZAVODNICK

Director · 3 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey Seery

Director · 3 shared filings (2 issuers)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

KK
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth Kay

Director · 3 shared filings (2 issuers)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

LD
No photo found yet (own website and image search run after this page is viewed)
Person

Len DeBenedictis

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

MM
No photo found yet (own website and image search run after this page is viewed)
Person

Marti Morfitt

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

WB
No photo found yet (own website and image search run after this page is viewed)
Person

William Brodie

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

RN
No photo found yet (own website and image search run after this page is viewed)
Person

Ramin (Ron) Najafi

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

TW
No photo found yet (own website and image search run after this page is viewed)
Person

Tony Wicks

Director · 2 shared filings (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

BS
No photo found yet (own website and image search run after this page is viewed)
Person

Brittany Slater

Executive Officer · 2 shared filings (2 issuers)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Cashion

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

LG
No photo found yet (own website and image search run after this page is viewed)
Person

Linda Graebner

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

David Holthe

Director · 1 shared filing (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

RW
No photo found yet (own website and image search run after this page is viewed)
Person

Roy J. Wu

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

John J. McGovern

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

YM
No photo found yet (own website and image search run after this page is viewed)
Person

Yonghao (Carl) Ma

Director · 1 shared filing (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

LS
No photo found yet (own website and image search run after this page is viewed)
Person

Lewis Stuart

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

JASON RALEIGH

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

GF
No photo found yet (own website and image search run after this page is viewed)
Person

Gary Fischer

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

DK
No photo found yet (own website and image search run after this page is viewed)
Person

Denise Keeler

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

PG
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Gainer

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Mark Sieczkarek. Their page shows their other deals.

The team behind the deals

Sponsor group

Solta

3 issuers · 9 filings · $25.7M reported sold · 2010–2022

One team, 3 deal companies. Mark Sieczkarek is listed on 3 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Mark Sieczkarek.

Same business address

3 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Mark Sieczkarek by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Mark Sieczkarek is listed on: none on file. No website or social profile named in SOLTA MEDICAL INC's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #332,229 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Hayward, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Mark Sieczkarek appears on a new Form D, or when a court case or SEC action is matched to them. See plans →